satavaptan has been researched along with transforming growth factor beta in 1 studies
| Studies (satavaptan) | Trials (satavaptan) | Recent Studies (post-2010) (satavaptan) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 95 | 11 | 30 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shibasaki, M; Tahara, A; Tomura, Y; Tsukada, J; Yatsu, T | 1 |
1 other study(ies) available for satavaptan and transforming growth factor beta
| Article | Year |
|---|---|
Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cells, Cultured; Collagen Type IV; Dose-Response Relationship, Drug; Male; Mesangial Cells; Morpholines; Piperidines; Rats; Rats, Wistar; Spiro Compounds; Transforming Growth Factor beta | 2008 |